Skip to main content
hello world

Closing Bell: Biosyent Inc up on Monday (RX)

Automated Summaries - The Globe and Mail - Mon Jul 29, 4:02PM CDT

In today's trading, Biosyent Inc shares closed at $10.10 after opening the day at $10.03. prices ranged from a low of $9.96 to a high of $10.10.

Shares boosted 0.20% from the previous day's close of $10.08.

Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

Trading volume was 2,608 on 12 total trades. On average, Biosyent Inc has traded 2,527 shares in the last five days and 6,567 year-to-date.

The TSX-V market on the whole today saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.46 (July 31,2023). Moreover, in the last 12 months, Biosyent Inc's shares have advanced 32.20%, while they have advanced 9.54% since the start of 2024.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $116.77 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..